The recommended cornerstone treatment for DR in developed countries, especially for Diabetic Macular Edema (DME) and Proliferative Diabetic Retinopathy (PDR), are intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) [20]. Here, VEGFA is linked to diabetic macular edema.